News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lupin Ltd. (LUPN.BO) to Buy Japanese Injectable Drugs Maker I'rom Pharma for Undisclosed Amount


11/17/2011 8:26:28 AM

Indian drugmaker Lupin will buy Japan's I'rom Pharmaceutical Co, its second buy in the country, to enter the generic injectables segment. The Mumbai-based Lupin had earlier bought Kyowa Pharmaceutical Industry Co in 2007. I'rom is a Tokyo-based speciality injectables drugmaker with annual sales of 5.36 billion yen ($69.7 million) for year ended March 2011, Lupin said in a statement without disclosing the deal value. I'rom Pharma, being acquired by Lupin's unit Kyowa, is a fully-owned subsidiary of I'rom Holdings Co, and has a significant presence in the fixed-rate treatment hospitals segment in Japan, where the government mandates clinics to offer low-cost healthcare services.

Read at Reuters
Read at Live Mint
Read at Wall Street Journal
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES